KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 79 filers reported holding KARYOPHARM THERAPEUTICS INC in Q3 2016. The put-call ratio across all filers is 0.13 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $1,889,000 | +5.9% | 256,291 | -7.6% | 0.00% | 0.0% |
Q4 2021 | $1,784,000 | +4.6% | 277,519 | -5.3% | 0.00% | 0.0% |
Q3 2021 | $1,706,000 | -4.2% | 293,130 | +70.0% | 0.00% | 0.0% |
Q2 2021 | $1,780,000 | +92.0% | 172,474 | +95.7% | 0.00% | 0.0% |
Q1 2021 | $927,000 | -24.2% | 88,111 | +11.6% | 0.00% | 0.0% |
Q4 2020 | $1,223,000 | +83.9% | 78,979 | +73.4% | 0.00% | – |
Q3 2020 | $665,000 | -75.7% | 45,538 | -68.5% | 0.00% | -100.0% |
Q2 2020 | $2,739,000 | -9.9% | 144,600 | -8.7% | 0.00% | -33.3% |
Q1 2020 | $3,041,000 | +56.4% | 158,310 | +56.1% | 0.00% | +200.0% |
Q4 2019 | $1,944,000 | +700.0% | 101,395 | +301.4% | 0.00% | – |
Q3 2019 | $243,000 | +89.8% | 25,261 | +18.0% | 0.00% | – |
Q2 2019 | $128,000 | -27.7% | 21,405 | +9.3% | 0.00% | – |
Q2 2017 | $177,000 | -50.7% | 19,583 | -30.0% | 0.00% | -100.0% |
Q1 2017 | $359,000 | +88.9% | 27,988 | +38.6% | 0.00% | – |
Q4 2016 | $190,000 | -2.1% | 20,199 | +1.4% | 0.00% | – |
Q3 2016 | $194,000 | -36.8% | 19,925 | +76.4% | 0.00% | -100.0% |
Q2 2015 | $307,000 | -26.7% | 11,298 | +0.8% | 0.00% | 0.0% |
Q4 2014 | $419,000 | – | 11,205 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Delphi Management Partners VIII, L.L.C. | 2,263,006 | $13,170,000 | 9.51% |
Palo Alto Investors LP | 5,383,052 | $31,329,000 | 1.89% |
Birchview Capital, LP | 246,000 | $1,432,000 | 0.97% |
Rubric Capital Management LP | 3,375,758 | $19,647,000 | 0.55% |
Lombard Odier Asset Management (Switzerland) SA | 1,517,804 | $8,834,000 | 0.55% |
RICE HALL JAMES & ASSOCIATES, LLC | 1,401,861 | $8,159,000 | 0.30% |
AlphaCentric Advisors LLC | 136,000 | $792,000 | 0.20% |
Bridgefront Capital, LLC | 20,946 | $122,000 | 0.13% |
Hennion & Walsh Asset Management, Inc. | 407,474 | $2,371,000 | 0.12% |
Virtus ETF Advisers LLC | 44,364 | $258,000 | 0.11% |